Share Buyback Plan Approved by AnaptysBio (NASDAQ:ANAB) Board
AnaptysBio (NASDAQ:ANAB – Get Free Report) declared that its Board of Directors has approved a stock buyback program on Monday, March 24th, RTT News reports. The company plans to buyback $75.00 million in shares. This buyback authorization allows the biotechnology company to reacquire up to 13.1% of its shares through open market purchases. Shares buyback […]
AnaptysBio (NASDAQ:ANAB – Get Free Report) declared that its Board of Directors has approved a stock buyback program on Monday, March 24th, RTT News reports. The company plans to buyback $75.00 million in shares. This buyback authorization allows the biotechnology company to reacquire up to 13.1% of its shares through open market purchases. Shares buyback […]
